Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Georgi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
JMIR Research Protocols|June 16, 2023
Variation in Experiences and Attainment in Surgery Between Ethnicities of UK Medical Students and Doctors (ATTAIN): Protocol for a Cross-Sectional StudySamar Babiker, Innocent Ogunmwonyi, Maria W Georgi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 TrialLars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
JMIR Research Protocols|June 16, 2023
Variation in Experiences and Attainment in Surgery Between Ethnicities of UK Medical Students and Doctors (ATTAIN): Protocol for a Cross-Sectional StudySamar Babiker, Innocent Ogunmwonyi, Maria W Georgi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Pediatric Blood & Cancer|May 27, 2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphomaFriedrich Christian Franke, Adrian Damek, Jonas Steglich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
Scientific Reports|June 25, 2024
Hodgkin lymphoma: hypodense lesions in mediastinal massesAdrian Damek, Lars Kurch, Friedrich Christian Franke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 TrialLars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Pageof 4